These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 30613963

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX, Nelson RA, Kim JY, Raz DJ.
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [Abstract] [Full Text] [Related]

  • 24. Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: An Australian population-based study.
    Ye Y, Otahal P, Wills KE, Neil AL, Venn AJ.
    Cancer; 2018 Apr 15; 124(8):1808-1818. PubMed ID: 29370456
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P.
    Cancer Causes Control; 2014 Jun 15; 25(6):659-68. PubMed ID: 24682745
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
    Vakharia PP, Kelm RC, Orrell KA, Patel KR, Singam V, Ali Y, Rastogi S, Yousif R, Rangel SM, West DP, Nardone B.
    Int J Dermatol; 2020 Apr 15; 59(4):463-468. PubMed ID: 31971260
    [Abstract] [Full Text] [Related]

  • 35. Excessive risk of second primary cancers in young-onset colorectal cancer survivors.
    He X, Wu W, Ding Y, Li Y, Si J, Sun L.
    Cancer Med; 2018 Apr 15; 7(4):1201-1210. PubMed ID: 29533011
    [Abstract] [Full Text] [Related]

  • 36. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
    Brown AP, Neeley ES, Werner T, Soisson AP, Burt RW, Gaffney DK.
    Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):127-35. PubMed ID: 19910129
    [Abstract] [Full Text] [Related]

  • 37. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP, Clarke CA, Aroner S, Swetter SM.
    J Am Acad Dermatol; 2010 May 01; 62(5):757-67. PubMed ID: 20223559
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS, Lu SE, Murphy JD, Romesser PB, Jethwa KR, Li D, Chundury A, Wu AJ, Hathout L, Hallemeier CL, Jabbour SK.
    Cancer Med; 2021 Jun 01; 10(11):3575-3583. PubMed ID: 33960690
    [Abstract] [Full Text] [Related]

  • 40. Second primary lung cancer in United States Cancer Survivors, 1992-2008.
    Donin NM, Kwan L, Lenis AT, Drakaki A, Chamie K.
    Cancer Causes Control; 2019 May 01; 30(5):465-475. PubMed ID: 30900065
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.